Trial intelligence / Profile preview

Ivabradine for Vascular Function in Stable CAD

NCT01768585Phase 4Unknown

Sponsor
Saarland University Medical Center
Start
Dec 2012
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ivabradine in coronary artery disease (CAD), sponsored by Saarland University Medical Center. Status: unknown.

02

Drugs

ivabradine
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT01768585.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01768585.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call